Analyst Ratings for Biohaven Pharma (BHVN)
BHVN Rating Summary
BHVN Price Target Summary
- Highest: $42.00 (Baird)
- Lowest: $9.00 (Bernstein SocGen Group)
- Average: $20.59
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$20.59 (+91%)
* Over Last 12-Mos
Rating Score: 6.4 / 10
Percentile Rank: 67%
Rating Score: 6.4 / 10
Percentile Rank: 67%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/8/2026 | RBC Capital | Leonid Timashev | Downgrade | Sector Perform (Outperform) |
19.00 (23.00) |
15.86 (10.78) |
-32.03% | Details |
| 6/29/2026 | BofA Securities | Jason Gerberry | Downgrade | Underperform (Neutral) |
11.00 (12.00) |
15.83 (10.78) |
-31.9% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
